NASDAQ: VBIV - VBI Vaccines Inc.

छह महीने के लिए लाभप्रदता: 0%
भाग प्रतिफल: 0.00%
सेक्टर: Healthcare

पदोन्नति कार्यक्रम VBI Vaccines Inc.

उन्नत शेड्यूल सरल ग्राफ
Financial Markets by TradingView

कंपनी के बारे में VBI Vaccines Inc.

VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines to treat immuno-oncology and infectious disease. It offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. The company also develops VBI-2601, an immunotherapeutic candidate for the treatment of chronic HBV infection; VBI-1901, a glioblastoma vaccine immunotherapeutic candidate, which is in Phase I/IIa clinical study to treat solid tumors; VBI-1501, a prophylactic cytomegalovirus vaccine candidate that has completed Phase I clinical trial; and VBI-2501 that is in preclinical trial to treat Zika virus.

अधिक जानकारी
In addition, it develops coronavirus vaccine candidates that include VBI-2902, VBI-2901, and VBI-2905. The company has collaboration and license agreements with Brii Biosciences Limited; GlaxoSmithKline Biologicals S.A.; and the National Research Council of Canada to develop pan-coronavirus vaccine candidate targeting COVID-19, severe acute respiratory syndrome, and Middle East respiratory syndrome. It also has a collaboration with Coalition for Epidemic Preparedness Innovations to advance vaccine candidates against Covid-19 variants. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. VBI Vaccines Inc. is based in Cambridge, Massachusetts.
तुलना सूची में जोड़ें
घड़ी सूची में जोड़ें
पोर्टफोलियो में जोड़ें
मूल्य सूचना जोड़ें

IPO date 1995-08-18
ISIN CA91822J1030
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Дивиденд ао 0.25
Сайт https://www.vbivaccines.com
Цена ао 0.0282
प्रति दिन मूल्य परिवर्तन: 0% (0.0282)
प्रति सप्ताह मूल्य परिवर्तन: 0% (0.0282)
प्रति माह मूल्य परिवर्तन: 0% (0.0282)
3 महीने में कीमत में बदलाव: 0% (0.0282)
छह महीने में कीमत में बदलाव: 0% (0.0282)
प्रति वर्ष मूल्य परिवर्तन: -95.14% (0.58)
3 वर्षों में मूल्य परिवर्तन: -98.34% (1.7)
5 वर्षों में मूल्य परिवर्तन: -96.14% (0.7307)
वर्ष की शुरुआत से मूल्य परिवर्तन: 0% (0.0282)
सभी पैरामीटर

बहुत मूल्यवान समझना

नाम अर्थ श्रेणी
P/S 0.9865 9
P/BV 1.14 9
P/E 0 0
EV/EBITDA -0.7112 0
कुल: 6

क्षमता

नाम अर्थ श्रेणी
ROA, % -106.77 0
ROE, % -1233.37 0
कुल: 0

लाभांश

नाम अर्थ श्रेणी
Div yield, % 0 0
DSI 0.7 7
कुल: 1.16

कर्तव्य

नाम अर्थ श्रेणी
Debt/EBITDA -0.9947 10
कुल: 7.8

विकास का आवेग

नाम अर्थ श्रेणी
लाभप्रदता Revenue, % 294.64 10
लाभप्रदता Ebitda, % 15.66 3
लाभप्रदता EPS, % -60.52 0
कुल: 4.6
अधिक जानकारी

संस्थानों आयतन शेयर करना, %
Perceptive Advisors LLC 1381355 5.83
Alyeska Investment Group, L.P. 696736 2.94
Geode Capital Management, LLC 138729 0.59
Blackrock Inc. 111960 0.47
Cambridge Investment Research Advisors Inc. 93556 0.39
Millennium Management LLC 71422 0.3
Vanguard Group Inc 64522 0.27
General American Investors Company Inc 62583 0.26
Morgan Stanley 34973 0.15
Northern Trust Corporation 32992 0.14



पर्यवेक्षक नौकरी का शीर्षक भुगतान जन्म का साल
Mr. Jeffery R. Baxter FCMA President, CEO & Director 908.06k 1961 (64 वर्ष)
Dr. Francisco Diaz-Mitoma FRCPC, M.D., Ph.D. Chief Medical Officer 544.52k 1955 (70 साल)
Ms. Nell Beattie CFO, Head of Corporate Development & Director N/A 1988 (37 साल)
Ms. Athena Kartsaklis Senior VP of Finance, Chief Compliance Officer & Principal Financial Officer N/A 1965 (60 साल)
Mr. Avi Mazaltov Global Head of Manufacturing & GM of SciVac N/A 1962 (63 वर्ष)
Mr. Misha Nossov Senior VP of Global Commercial Supply Strategy & Head of Europe N/A
Mr. John Robert Dillman Chief Commercial Officer N/A 1968 (57 साल)
Dr. David Evander Anderson Ph.D. Chief Scientific Officer 1970 (55 साल)
Ms. Nicole Anderson Director of Corporate Communications & Investor Relations
Mr. T. Adam Buckley B.Sc., MBA Senior Vice President of Business Development 1976 (49 साल)

पता: United States, Cambridge. MA, 160 Second Street - Google मानचित्र में खोलें, यांडेक्स मानचित्र खोलें
वेबसाइट: https://www.vbivaccines.com